Key facts
- This page summarizes D. Scott Barbour's Form 4 filing for Allison Transmission Holdings Inc (ALSN).
- 5 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 08 May 2026, 16:00.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Options Exercise
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Options Exercise
Award
Additional SEC filing notes
Footnote F1
These shares represent a quarterly payment of the reporting person's annual retainer under the Allison Transmission Holdings, Inc. (the "Company") Eighth Amended and Restated Non-Employee Director Compensation Policy. The annual retainer is paid quarterly in arrears in cash or common stock at the reporting person's discretion.
Footnote F2
The number of shares of common stock received was calculated based on $127.70 which was the closing price of the Company's common stock on the date of grant.
Footnote F3
Settlement of restricted stock units ("RSUs") and related dividend equivalents.
Footnote F4
Includes 16 dividend equivalents.
Footnote F5
Each RSU represents a contingent right to receive one share of the Company's common stock.
Footnote F6
On May 8, 2025, the reporting person was granted 1,570 RSUs that vested on May 6, 2026.
Footnote F7
Each dividend equivalent right is the economic equivalent of one share of the Company's common stock.
Footnote F8
The dividend equivalent rights accrued on previously awarded RSUs and vested on May 6, 2026.
Footnote F9
The RSUs represent the reporting person's annual equity award under the Company's Ninth Amended and Restated Non-Employee Director Compensation Policy.
Footnote F10
The RSUs vest on the date of the next annual meeting of the stockholders of the Company. Unvested RSUs earn dividend equivalents when dividends are declared on the Company's common stock.
Footnote F11
The number of RSUs received was calculated based on $123.02, which was the closing price of the Company's common stock on the date of grant.